Second Line Breast Cancer Trial

Clinical trial NCT00635713 · COMPLETED

Trial details

NCT number: NCT00635713
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 1997-05-01
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.